MedPath

Manhattan Pharmaceuticals

Manhattan Pharmaceuticals logo
🇺🇸United States
Ownership
Private
Employees
1
Market Cap
-
Website
http://manhattanpharma.com

A Safety and Efficacy Study of a Topical Gel for the Treatment of Mild to Moderate Psoriasis

Phase 2
Completed
Conditions
Psoriasis Vulgaris
Interventions
First Posted Date
2008-01-14
Last Posted Date
2008-08-19
Lead Sponsor
Manhattan Pharmaceuticals
Target Recruit Count
61
Registration Number
NCT00593177
Locations
🇺🇸

Therapeutics Clinical Research, San Diego, California, United States

🇺🇸

Advanced Dermatology and Cosmetic Surgery, Ormond Beach, Florida, United States

🇺🇸

Minnesota Clinical Study Center, Fridley, Minnesota, United States

and more 1 locations

Phase 2a Randomized, Double-Blind Study of Oleoyl-Estrone in Male Morbidly Obese Adults

Phase 2
Conditions
Obesity
First Posted Date
2007-03-20
Last Posted Date
2007-06-05
Lead Sponsor
Manhattan Pharmaceuticals
Target Recruit Count
24
Registration Number
NCT00449254
Locations
🇺🇸

St. Luke's-Roosevelt Hospital, New York, New York, United States

🇺🇸

Research Across America, Dallas, Texas, United States

🇺🇸

Jean Brown Research, Salt Lake City, Utah, United States

Phase 2a Obesity Study of Oral Doses of Oleoyl-Estrone (MP-101)

Phase 2
Conditions
Obesity
First Posted Date
2007-03-20
Last Posted Date
2007-03-20
Lead Sponsor
Manhattan Pharmaceuticals
Target Recruit Count
100
Registration Number
NCT00449202
Locations
🇺🇸

Pennington Biomedical Research, Baton Rouge, Louisiana, United States

🇺🇸

Jean Brown Research, Salt Lake City, Utah, United States

🇨🇭

Swiss Pharma Contract, Basel, Switzerland

© Copyright 2025. All Rights Reserved by MedPath